12/08/2022: Lab Update: CDC Updates Guidance for Collection and Transport of Specimens for Ebolavirus Testing and Routine Diagnostic Testing for Patients with Suspected Ebola Disease
Audience: Clinical Laboratories
Level: Laboratory Update
On Wednesday, December 7, 2022, the U.S. Centers for Disease Control and Prevention (CDC) updated the guidance for the Collection, Transport and Submission of Specimens for Ebolavirus Testing and U.S. Hospitals and Clinical Laboratories on Performing Routine Diagnostic Testing for Patients with Suspected Ebola Disease.
Although the risk of a travel-associated Sudan virus case in the United States is low, CDC recommends clinical laboratories review both web pages in detail for more information.
We encourage you to share this message widely with your networks.
Opt-in to receive updates from the CDC Laboratory Outreach Communication System.
Resources
- CDC Ebola Virus Disease Website
- Guidance for Collection, Transport and Submission of Specimens for Ebola Virus Testing
- Guidance for U.S. Hospitals and Clinical Laboratories on Performing Routine Diagnostic Testing for Patients with Suspected Ebola Disease
- Department of Transportation Transporting Infectious Substances Overview
- Department of Transportation Transporting Infectious Substances Safely
- eCFR :: 49 CFR 173.196 — Category A infectious substances
Questions?
- If you are a clinical or public health laboratory professional, contact LOCS.
- For media inquiries, contact the CDC Newsroom.
- For all other questions, contact CDC-INFO.
Thank you,
The Laboratory Outreach Communication System
Laboratory Outreach Communication System (LOCS) | Division of Laboratory Systems (DLS)
Center for Surveillance, Epidemiology, and Laboratory Services (CSELS)
Centers for Disease Control and Prevention (CDC)